Literature DB >> 29395536

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.

Johan Vekemans1, Vasee Moorthy2, Brigitta Giersing2, Martin Friede2, Joachim Hombach2, Narendra Arora3, Kayvon Modjarrad4, Peter G Smith5, Ruth Karron6, Barney Graham7, David C Kaslow8.   

Abstract

The respiratory syncytial virus causes a considerable respiratory disease burden globally, most markedly in young infants, in low and middle income countries. A diverse product pipeline illustrates the recent intensification of research and development activities for vaccines and monoclonal antibodies against RSV. With the aim to ensure that product development activities are directed to address the public health needs, the World Health Organization has developed a research and development technical roadmap and articulated product characteristics preferences.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Maternal immunization; Research and development; Respiratory syncytial virus; Vaccines

Mesh：

Substances：

Year:  2018        PMID： 29395536     DOI： 10.1016/j.vaccine.2017.09.092

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  16 in total

1.  Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial.

Authors:  Katia Abarca; Emma Rey-Jurado; Natalia Muñoz-Durango; Yaneisi Vázquez; Jorge A Soto; Nicolás M S Gálvez; Javier Valdés-Ferrada; Carolina Iturriaga; Marcela Urzúa; Arturo Borzutzky; Jaime Cerda; Luis Villarroel; Victoria Madrid; Pablo A González; José V González-Aramundiz; Susan M Bueno; Alexis M Kalergis
Journal:  EClinicalMedicine       Date:  2020-10-06

Review 2.  The journey to a respiratory syncytial virus vaccine.

Authors:  Asuncion Mejias; Rosa Rodríguez-Fernández; Silvia Oliva; Mark E Peeples; Octavio Ramilo
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-23       Impact factor: 6.347

3.  Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection.

Authors:  Maximillian S Habibi; Ryan S Thwaites; Christopher Chiu; Peter J M Openshaw; Meiping Chang; Agnieszka Jozwik; Allan Paras; Freja Kirsebom; Augusto Varese; Amber Owen; Leah Cuthbertson; Phillip James; Tanushree Tunstall; David Nickle; Trevor T Hansel; Miriam F Moffatt; Cecilia Johansson
Journal:  Science       Date:  2020-10-09       Impact factor: 63.714

4.  The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs.

Authors:  Flor M Munoz; Pierre Van Damme; Ener Dinleyici; Ed Clarke; Beate Kampmann; Paul T Heath; Ofer Levy; Elke Leuridan; Clare Cutland; Ajoke Sobanjo-Ter Meulen; Arnaud Marchant
Journal:  mSphere       Date:  2018-11-07       Impact factor: 4.389

5.  Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.

Authors:  Corinne A Riddell; Niranjan Bhat; Louis J Bont; William D Dupont; Daniel R Feikin; Deshayne B Fell; Tebeb Gebretsadik; Tina V Hartert; Jennifer A Hutcheon; Ruth A Karron; Harish Nair; Robert C Reiner; Ting Shi; Peter D Sly; Renato T Stein; Pingsheng Wu; Heather J Zar; Justin R Ortiz
Journal:  Vaccine       Date:  2018-11-22       Impact factor: 3.641

Review 6.  Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations.

Authors:  Sonali Kochhar; Kathryn M Edwards; Alba Maria Ropero Alvarez; Pedro L Moro; Justin R Ortiz
Journal:  Vaccine       Date:  2019-05-06       Impact factor: 3.641

7.  Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali.

Authors:  Andrea G Buchwald; Boubou Tamboura; Sharon M Tennant; Fadima C Haidara; Flanon Coulibaly; Moussa Doumbia; Fatoumata Diallo; Adama M Keita; Samba O Sow; Karen L Kotloff; Myron M Levine; Milagritos D Tapia
Journal:  Clin Infect Dis       Date:  2020-01-01       Impact factor: 9.079

8.  Original Antigenic Sin and Respiratory Syncytial Virus Vaccines.

Authors:  Ralph A Tripp; Ultan F Power
Journal:  Vaccines (Basel)       Date:  2019-09-06

9.  Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development.

Authors:  Julia Dubois; Andrés Pizzorno; Marie-Hélène Cavanagh; Blandine Padey; Claire Nicolas de Lamballerie; Olus Uyar; Marie-Christine Venable; Julie Carbonneau; Aurélien Traversier; Thomas Julien; Sophie Lavigne; Christian Couture; Bruno Lina; Marie-Ève Hamelin; Olivier Terrier; Manuel Rosa-Calatrava; Guy Boivin
Journal:  Vaccines (Basel)       Date:  2019-10-30

10.  Drivers and barriers of vaccine acceptance among pregnant women in Kenya.

Authors:  Nancy A Otieno; Fredrick Otiato; Bryan Nyawanda; Maxwel Adero; Winnie N Wairimu; Dominic Ouma; Raphael Atito; Andrew Wilson; Ines Gonzalez-Casanova; Fauzia A Malik; Marc-Alain Widdowson; Saad B Omer; Sandra S Chaves; Jennifer R Verani
Journal:  Hum Vaccin Immunother       Date:  2020-03-25       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.